|

| 产地 | France |
| 品牌 | AntibodySystem |
| 货号 | YHC37501 |
| 用途 | 仅用于科研 |
| 包装规格 | 100 μg |
| 纯度 | 0.95% |
| CAS编号 | |
| 是否进口 | 否 |
| 货号 | YHC37501 |
| 产品名称 | Recombinant Human NMB Protein, N-GST |
| 规格 | 100 μg |
| 价格 | 1880 |
| 状态 | Lyophilized |
| 储存缓冲液 | Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol. |
| 纯度 | >90% as determined by SDS-PAGE. |
| 应用 | ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress |
| 内毒水平 | Please contact with the lab for this information. |
| 表达系统 | E. coli |
| Accession | P08949 |
| 蛋白长度 | Ala25-Lys121 |
| 预测分子量 | 37.66 kDa |
| 稳定性与储存条件 | Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt. |
| 重悬 | Reconstitute in sterile water for a stock solution. |
| 别名 | NMB, Neuromedin-B |
| 物种 | Homo sapiens (Human) |
| 运输 | In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise. |
| 备注 | For research use only. |
背景介绍:
NMB(神经介素 B)是一类神经肽分子,广泛分布于中枢及外周组织。通过结合对应的受体参与信号传导,调控摄食行为、痛觉感知与体液调节活动。其表达水平异常会扰乱机体生理平衡,是神经调节方向研究的常用靶点。
前沿相关研究:
1.Phase 1 study of the pharmacokinetics and clinical proof-of-concept activity of a biofilm-disrupting human monoclonal antibody in patients with chronic prosthetic joint infection of the knee or hip., PMID:39012102
2.Evaluation of a bimodal, matched pair theranostic agent targeting prostate-specific membrane antigen., PMID:39032262
3.The TGF-β1 target WISP1 is highly expressed in liver cirrhosis and cirrhotic HCC microenvironment and involved in pro- and anti-tumorigenic effects., PMID:39033550
4.Prostaglandin E2 regulates the plasminogen activator pathway in human endometrial endothelial cells: a new in vitro model to investigate heavy menstrual bleeding., PMID:39038609
5.Seasonal Proteome Variations in Orbicella faveolata Reveal Molecular Thermal Stress Adaptations., PMID:39051238
6.Functional status and quality of life in older patients with advanced esophageal squamous cell cancer receiving second-line nivolumab ± ipilimumab therapy: A post hoc analysis of the phase 2, multicenter RAMONA study., PMID:39097500
7.Synthesis and preclinical evaluation of [18F]AlF-NODA-MP-C6-CTHRSSVVC as a PET tracer for CD163-positive tumor-infiltrating macrophages., PMID:39151305